The medical cannabis market is experiencing rapid growth and transformation, driven by increasing recognition of cannabis as a viable therapeutic option. In 2022, the market reached an impressive valuation of USD 11.60 billion, and it is projected to soar to USD 40.48 billion by 2032, expanding at a remarkable compound annual growth rate (CAGR) of 13.8%. This growth trajectory highlights the expanding role of cannabis-based products in healthcare, fueled by advancements in cultivation, processing, and distribution. As the market continues to evolve, strategic partnerships, regulatory developments, and research innovations are all playing crucial roles in shaping the future of this industry.
Get All the Details in Our Solution – Download Brochure @ https://www.towardshealthcare.com/download-brochure/5099
A key driver of this growth is the entry of large pharmaceutical and biotech companies into the medical cannabis space. These established players are focusing on the research and development of cannabis-based drugs that meet stringent regulatory standards, enabling broader acceptance and market expansion. As these companies integrate cannabis into their portfolios, the competitive dynamics in the medical cannabis market continue to evolve, pushing the boundaries of innovation and regulatory compliance.
The medical cannabis market is multifaceted, with chronic pain management taking the lead as the largest segment. In 2022, chronic pain treatments accounted for 52% of the market share, underscoring the growing recognition of cannabis as an effective alternative to traditional pain management therapies. With increasing global demand for pain relief and a shift toward more natural treatment options, the medical cannabis sector is expected to see continued expansion in this area.
Geographically, North America remains the dominant player in the market, commanding 56% of the global share. This dominance can be attributed to early legalization efforts, a well-established market, and the growing popularity of medical cannabis among patients. As more states in the U.S. and provinces in Canada legalize medical cannabis, the region is poised to continue its leadership role in the global market.
In January 2023, Celadon Pharmaceuticals Pic made a significant announcement, sharing that the UK Medicines and Healthcare Products Regulatory Agency (MHRA) had officially registered its cannabis active pharmaceutical ingredient (API) at its Midlands facility. This milestone ensures that Celadon complies with Good Manufacturing Practices (GMP), a critical requirement for the production of medical cannabis. The registration strengthens the company’s position in the growing UK market and highlights the increasing importance of meeting regulatory standards in the cannabis industry.
In February 2023, Aurora Cannabis Inc., a global leader in the cannabis sector, formed a strategic partnership with MedReleaf Australia. Together, they introduced CraftPlant, a new medical cannabis brand aimed at the Australian market. CraftPlant offers three unique products—Greendale, Navana, and HiVolt—all derived from specially cultivated cannabis strains with high levels of tetrahydrocannabinol (THC) and enriched with terpenes. This collaboration provides Australian doctors with a variety of prescription options, enhancing patient access to tailored cannabis-based treatments.
June 2023 marked another milestone for Avicanna Inc., a trailblazer in cannabinoid-based pharmaceuticals, as the company joined forces with the Canadian Consortium for the Investigation of Cannabinoids (CCIC). The partnership led to the development of an educational course specifically designed for the medical community in Canada. This initiative aims to increase understanding of cannabinoids and their potential applications in patient care, further bridging the gap between science and medical practice.
Continuing its expansion, Avicanna made another strategic move in August 2023 by acquiring Medical Cannabis by Shopper’s Business from Shoppers Drug Mart. This acquisition not only expanded Avicanna’s market presence but also marked the launch of MyMedi.ca, a digital platform offering a comprehensive and user-friendly experience for individuals seeking medical cannabis solutions. MyMedi.ca is designed to make it easier for patients to access information, products, and guidance related to their medical cannabis needs, positioning Avicanna as a leader in patient-centered care.
The medical cannabis market continues to grow, driven by innovations in cultivation techniques, product development, and regulatory frameworks. As new players enter the space and established companies enhance their portfolios, the competitive landscape is becoming increasingly complex. The market is projected to quadruple by 2032, with a sizzling CAGR of 13.8%. Regulatory changes, advancements in cannabinoid research, and strategic collaborations will shape the future of the industry, providing new opportunities for growth while ensuring patient safety and quality standards remain at the forefront.
As the industry continues to expand globally, the competitive dynamics within the medical cannabis market are expected to evolve further. The ongoing developments mentioned above are just the beginning of what promises to be an exciting era for medical cannabis, with advancements poised to benefit both patients and the companies providing them with access to life-changing therapies. With North America leading the way, other regions will likely follow suit, fueling the widespread adoption of medical cannabis in healthcare worldwide.
Our Table of Content (TOC) covers key healthcare market segments, materials, technologies and trends—helping you navigate market shifts and make informed decisions: https://www.towardshealthcare.com/table-of-content/medical-cannabis-market-size
Invest in Our Premium Strategic Solution @ https://www.towardshealthcare.com/price/5099
We’ve prepared a service to support you. Please feel free to contact us at sales@towardshealthcare.com
Web: https://www.towardshealthcare.com
Visit Dental Specifics: https://www.towardsdental.com
Get the latest insights on industry segmentation with our Annual Membership: Get a Subscription
For Latest Update Follow Us: https://www.linkedin.com/company/towards-healthcare
Bone-related disorders, including bone cancer, bone infections, and spinal cord injuries, have become significant health concerns across the globe. These… Read More
The healthcare industry is continually evolving to meet the challenges of rising administrative costs, regulatory compliance, and the need for… Read More
Cloud computing has revolutionized the way services are delivered across various industries, and healthcare is no exception. In today’s digital… Read More
The healthcare sector is experiencing a paradigm shift with the rapid adoption of artificial intelligence (AI) and digital technologies. These… Read More
The corporate wellness industry has seen significant advancements in recent years, with artificial intelligence (AI) playing a pivotal role in… Read More
AI is transforming industries across the globe, and the automated cell counting market is no exception. Traditionally, cell counting has… Read More